Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ishan Capila

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Angewandte Chemie (International Ed. in English)|December 20, 2002
Heparin-protein interactionsIshan Capila, Robert J Linhardt
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
The structural elucidation of glycosaminoglycansVikas Prabhakar, Ishan Capila, Ram Sasisekharan
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Glycosaminoglycan characterization methodologies: probing biomolecular interactionsVikas Prabhakar, Ishan Capila, Ram Sasisekharan
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Mass spectrometric methods for the analysis of heparin and heparan sulfateMiroslaw Lech, Ishan Capila, Ganesh V Kaundinya
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2021
Mass Spectrometric Methods for the Analysis of Heparin and Heparan SulfateMiroslaw Lech, Ishan Capila, Ganesh V Kaundinya
Handbook of Experimental Pharmacology|May 9, 2012
Heparin and heparan sulfate: analyzing structure and microheterogeneityZachary Shriver, Ishan Capila, Ganesh Venkataraman, et al.
The Journal of Biological Chemistry|October 14, 2008
Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgarisVikas Prabhakar, Ishan Capila, Venkataramanan Soundararajan, et al.
The Biochemical Journal|February 5, 2005
Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant expression and active site identificationVikas Prabhakar, Ishan Capila, Carlos J Bosques, et al.
Mabs|August 2, 2018
Data-independent oxonium ion profiling of multi-glycosylated biotherapeuticsJames A Madsen, Victor Farutin, Yin Yin Lin, et al.
Viruses|December 23, 2022
Optimizing Antibody Affinity and Developability Using a Framework-CDR Shuffling Approach-Application to an Anti-SARS-CoV-2 AntibodyRanjani Gopal, Emmett Fitzpatrick, Niharika Pentakota, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Angewandte Chemie (International Ed. in English)|December 20, 2002
Heparin-protein interactionsIshan Capila, Robert J Linhardt
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
The structural elucidation of glycosaminoglycansVikas Prabhakar, Ishan Capila, Ram Sasisekharan
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Glycosaminoglycan characterization methodologies: probing biomolecular interactionsVikas Prabhakar, Ishan Capila, Ram Sasisekharan
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Mass spectrometric methods for the analysis of heparin and heparan sulfateMiroslaw Lech, Ishan Capila, Ganesh V Kaundinya
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2021
Mass Spectrometric Methods for the Analysis of Heparin and Heparan SulfateMiroslaw Lech, Ishan Capila, Ganesh V Kaundinya
Handbook of Experimental Pharmacology|May 9, 2012
Heparin and heparan sulfate: analyzing structure and microheterogeneityZachary Shriver, Ishan Capila, Ganesh Venkataraman, et al.
The Journal of Biological Chemistry|October 14, 2008
Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgarisVikas Prabhakar, Ishan Capila, Venkataramanan Soundararajan, et al.
The Biochemical Journal|February 5, 2005
Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant expression and active site identificationVikas Prabhakar, Ishan Capila, Carlos J Bosques, et al.
Mabs|August 2, 2018
Data-independent oxonium ion profiling of multi-glycosylated biotherapeuticsJames A Madsen, Victor Farutin, Yin Yin Lin, et al.
Viruses|December 23, 2022
Optimizing Antibody Affinity and Developability Using a Framework-CDR Shuffling Approach-Application to an Anti-SARS-CoV-2 AntibodyRanjani Gopal, Emmett Fitzpatrick, Niharika Pentakota, et al.
Pageof 5